AMRI and Proteros Biostructures have signed an agreement for a joint offering to the life sciences industry. Proteros will provide protein crystallization and X-ray structural analysis services that complement AMRI’s existing drug discovery capabilities in chemistry, in vitro biology, drug metabolism and pharmacokinetics services. According to a joint statement, “Proteros’ expertise in structural biology services combined with AMRI’s expansive discovery and development capabilities provid...